These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 18498242

  • 1. Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes.
    Marcovecchio ML, Widmer B, Dunger DB, Dalton RN.
    Clin Sci (Lond); 2008 Dec; 115(12):361-9. PubMed ID: 18498242
    [Abstract] [Full Text] [Related]

  • 2. Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.
    Cighetti G, Fermo I, Aman CS, Ferraroni M, Secchi A, Fiorina P, Paroni R.
    Free Radic Biol Med; 2009 Aug 01; 47(3):307-11. PubMed ID: 19446631
    [Abstract] [Full Text] [Related]

  • 3. Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.
    Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G.
    Endocrinology; 2008 Jun 01; 149(6):3148-57. PubMed ID: 18292189
    [Abstract] [Full Text] [Related]

  • 4. Changes in plasma levels of asymmetric dimethylarginine, symmetric dimethylarginine, and arginine after a single dose of vardenafil in patients with pulmonary hypertension.
    Henrohn D, Sandqvist A, Egeröd H, Hedeland M, Wernroth L, Bondesson U, Wikström G.
    Vascul Pharmacol; 2015 Oct 01; 73():71-7. PubMed ID: 25934511
    [Abstract] [Full Text] [Related]

  • 5. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
    Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.
    Diabetes Care; 2004 Mar 01; 27(3):765-9. PubMed ID: 14988299
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover.
    Marliss EB, Chevalier S, Gougeon R, Morais JA, Lamarche M, Adegoke OA, Wu G.
    Diabetologia; 2006 Feb 01; 49(2):351-9. PubMed ID: 16369774
    [Abstract] [Full Text] [Related]

  • 8. Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA(1c).
    Marcovecchio ML, Widmer B, Turner C, Dunger DB, Dalton RN.
    Diabet Med; 2011 Jun 01; 28(6):685-91. PubMed ID: 21294768
    [Abstract] [Full Text] [Related]

  • 9. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M, Fleck C, Wolf G, Stein G.
    Amino Acids; 2006 May 01; 30(3):225-32. PubMed ID: 16680555
    [Abstract] [Full Text] [Related]

  • 10. Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.
    Eid HM, Reims H, Arnesen H, Kjeldsen SE, Lyberg T, Seljeflot I.
    Metabolism; 2007 Apr 01; 56(4):464-9. PubMed ID: 17379002
    [Abstract] [Full Text] [Related]

  • 11. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.
    Mittermayer F, Kautzky-Willer A, Winzer C, Krzyzanowska K, Prikoszovich T, Demehri S, Wagner O, Wolzt M.
    J Intern Med; 2007 Apr 01; 261(4):392-8. PubMed ID: 17391114
    [Abstract] [Full Text] [Related]

  • 12. Asymmetric dimethylarginine levels in thyroid diseases.
    Arikan E, Karadag CH, Guldiken S.
    J Endocrinol Invest; 2007 Mar 01; 30(3):186-91. PubMed ID: 17505150
    [Abstract] [Full Text] [Related]

  • 13. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M, Teerlink T.
    Metabolism; 2013 Oct 01; 62(10):1455-61. PubMed ID: 23890667
    [Abstract] [Full Text] [Related]

  • 14. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
    Fleck C, Janz A, Schweitzer F, Karge E, Schwertfeger M, Stein G.
    Kidney Int Suppl; 2001 Feb 01; 78():S14-8. PubMed ID: 11168976
    [Abstract] [Full Text] [Related]

  • 15. Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus.
    Mittermayer F, Pleiner J, Krzyzanowska K, Wiesinger GF, Francesconi M, Wolzt M.
    Wien Klin Wochenschr; 2005 Dec 01; 117(23-24):816-20. PubMed ID: 16437318
    [Abstract] [Full Text] [Related]

  • 16. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
    Erdélyi-Bótor S, Komáromy H, Kamson DO, Kovács N, Perlaki G, Orsi G, Molnár T, Illes Z, Nagy L, Kéki S, Deli G, Bosnyák E, Trauninger A, Pfund Z.
    Cephalalgia; 2017 May 01; 37(6):571-580. PubMed ID: 27206959
    [Abstract] [Full Text] [Related]

  • 17. Diagnostical significance of dimethylarginine in the development of hepatorenal syndrome in patients with alcoholic liver cirrhosis.
    Nicković V, Nikolić J, Djindjić N, Ilić M, Nicković J, Mladenović D, Krstić N.
    Vojnosanit Pregl; 2012 Aug 01; 69(8):686-91. PubMed ID: 22924265
    [Abstract] [Full Text] [Related]

  • 18. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.
    Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, Toruner FB.
    J Clin Endocrinol Metab; 2007 May 01; 92(5):1881-5. PubMed ID: 17311854
    [Abstract] [Full Text] [Related]

  • 19. Symmetric dimethylarginine, an endogenous marker of glomerular filtration rate, and the risk for microalbuminuria in young people with type 1 diabetes.
    Marcovecchio ML, Dalton RN, Turner C, Prevost AT, Widmer B, Amin R, Dunger DB.
    Arch Dis Child; 2010 Feb 01; 95(2):119-24. PubMed ID: 19948509
    [Abstract] [Full Text] [Related]

  • 20. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M, Karimi-Jafari H, Esteghamati A, Khalilzadeh O, Asgarani F, Ghadiri-Anari A.
    Ann Endocrinol (Paris); 2010 Sep 01; 71(4):303-8. PubMed ID: 20434720
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.